Terms: = Sarcomas AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400
663 results:
1. Establishment, characterization, and genetic profiling of patient-derived osteosarcoma cells from a patient with retinoblastoma.
Thongkumkoon P; Sangphukieo A; Tongjai S; Noisagul P; Sangkhathat S; Laochareonsuk W; Kamolphiwong R; Budprom P; Teeyakasem P; Yongpitakwattana P; Thepbundit V; Sirikaew N; Klangjorhor J; Settakorn J; Moonmuang S; Suksakit P; Pasena A; Chaijaruwanich J; Yathongkhum W; Dissook S; Pruksakorn D; Chaiyawat P
Sci Rep; 2024 May; 14(1):11056. PubMed ID: 38744935
[TBL] [Abstract] [Full Text] [Related]
2. Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma.
Saoud C; Dermawan JK; Sharma AE; Tap W; Wexler LH; Antonescu CR
Genes Chromosomes Cancer; 2024 May; 63(5):e23238. PubMed ID: 38722224
[TBL] [Abstract] [Full Text] [Related]
3. Principles in the Management of Glioblastoma.
Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
[TBL] [Abstract] [Full Text] [Related]
4. Role of Protein Tyrosine Phosphatase Receptor Type E (PTPRE) in Chemoresistant Retinoblastoma.
Mohren L; Doege A; Miroschnikov N; Dräger O; Busch MA; Dünker N
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674157
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive Transcriptomic Analysis of EWSR1::WT1 Targets Identifies CDK4/6 Inhibitors as an Effective Therapy for Desmoplastic Small Round Cell Tumors.
Magrath JW; Sampath SS; Flinchum DA; Hartono AB; Goldberg IN; Boehling JR; Savkovic SD; Lee SB
Cancer Res; 2024 May; 84(9):1426-1442. PubMed ID: 38588409
[TBL] [Abstract] [Full Text] [Related]
6. Uterine Leiomyosarcoma Associated With Perivascular Epithelioid Cell Tumor: A Phenomenon of Differentiation/Dedifferentiation and Evidence Suggesting Cell-of-Origin.
Katsakhyan L; Shahi M; Eugene HC; Nonogaki H; Gross JM; Nucci MR; Vang R; Xing D
Am J Surg Pathol; 2024 Jun; 48(6):761-772. PubMed ID: 38497360
[TBL] [Abstract] [Full Text] [Related]
7. Developing Novel Genomic Risk Stratification Models in Soft Tissue and Uterine Leiomyosarcoma.
Dermawan JK; Chiang S; Singer S; Jadeja B; Hensley ML; Tap WD; Movva S; Maki RG; Antonescu CR
Clin Cancer Res; 2024 May; 30(10):2260-2271. PubMed ID: 38488807
[TBL] [Abstract] [Full Text] [Related]
8. PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancer.
Lin CC; Chang TC; Wang Y; Guo L; Gao Y; Bikorimana E; Lemoff A; Fang YV; Zhang H; Zhang Y; Ye D; Soria-Bretones I; Servetto A; Lee KM; Luo X; Otto JJ; Akamatsu H; Napolitano F; Mani R; Cescon DW; Xu L; Xie Y; Mendell JT; Hanker AB; Arteaga CL
Nat Commun; 2024 Mar; 15(1):2287. PubMed ID: 38480701
[TBL] [Abstract] [Full Text] [Related]
9. Atypical Spindle Cell/Pleomorphic Lipomatous Tumor With Sarcomatous Transformation: Clinicopathologic and Molecular Analysis of 4 Cases.
Perret R; Charville GW; Alame M; Rebier F; Soubeyran I; Gross JM; Graham D; Green DC; Kerr DA; Khan WA; Cloutier JM
Mod Pathol; 2024 Apr; 37(4):100454. PubMed ID: 38417627
[TBL] [Abstract] [Full Text] [Related]
10. Pan-cancer Genomic Analysis of AXL Mutations Reveals a Novel, Recurrent, Functionally Activating AXL W451C Alteration Specific to Myxofibrosarcoma.
Williams EA; Vegas I; El-Senduny FF; Zhang J; Mata DA; Hiemenz MC; Hughes SR; Sa BC; Kraft GP; Gorbatov N; Foley-Peres K; Sanchez EZ; Milikowski C; Williams KJ; Ross JS; Kurzrock R; Montgomery EA; Lombard DB; Kumar S
Am J Surg Pathol; 2024 Jun; 48(6):699-707. PubMed ID: 38369783
[TBL] [Abstract] [Full Text] [Related]
11. Targeted inhibition of SCF
Wang J; Ferrena A; Zhang R; Singh S; Viscarret V; Al-Harden W; Aldahamsheh O; Borjihan H; Singla A; Yaguare S; Tingling J; Zi X; Lo Y; Gorlick R; Schwartz EL; Zhao H; Yang R; Geller DS; Zheng D; Hoang BH
Oncogene; 2024 Mar; 43(13):962-975. PubMed ID: 38355807
[TBL] [Abstract] [Full Text] [Related]
12. When the second comes first- rhabdomyosarcoma preceding heritable retinoblastoma- a case report.
Tripathy D; Moulin A; Bijon J; Gengler C; Beck-Popovic M; Munier FL; Stathopoulos C
BMC Ophthalmol; 2024 Jan; 24(1):47. PubMed ID: 38291358
[TBL] [Abstract] [Full Text] [Related]
13. Atypical Spindle Cell/Pleomorphic Lipomatous Tumor.
Qorbani A; Horvai A
Surg Pathol Clin; 2024 Mar; 17(1):97-104. PubMed ID: 38278611
[TBL] [Abstract] [Full Text] [Related]
14. Proteomics and genomics insights on malignant osteosarcoma.
Kathiresan N; Selvaraj C; Pandian S; Subbaraj GK; Alothaim AS; Safi SZ; Kulathaivel L
Adv Protein Chem Struct Biol; 2024; 138():275-300. PubMed ID: 38220428
[TBL] [Abstract] [Full Text] [Related]
15. A study protocol for an open-label, single-arm, single-center phase I clinical study on tolerability, safety, and efficacy of dalpiciclib combined with apatinib in the treatment of patients with advanced or metastatic sarcoma.
Huang H; Zhang H; Cao B
Thorac Cancer; 2024 Feb; 15(5):427-433. PubMed ID: 38211967
[TBL] [Abstract] [Full Text] [Related]
16. Genetically engineered mouse model of pleomorphic liposarcoma: Immunophenotyping and histologic characterization.
Brown JM; Patel R; Smith-Fry K; Ward M; Oliver T; Jones KB
Neoplasia; 2024 Feb; 48():100956. PubMed ID: 38199172
[TBL] [Abstract] [Full Text] [Related]
17. Rare myxoid pleomorphic liposarcoma: a case report and literature review.
Shen Y; Zhao L; Li A; Peng Q; Liu Q; Wang L; Liu Z
J Clin Pathol; 2024 Apr; 77(5):358-362. PubMed ID: 38123348
[TBL] [Abstract] [Full Text] [Related]
18. Genetic Profiling Uncovers Genome-Wide Loss of Heterozygosity and Provides Insight into Mechanisms of Sarcomatoid Transformation in Chromophobe Renal Cell Carcinoma.
Collins K; Acosta AM; Siegmund SE; Cheng L; Hirsch MS; Idrees MT
Mod Pathol; 2024 Feb; 37(2):100396. PubMed ID: 38043790
[TBL] [Abstract] [Full Text] [Related]
19. CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.
Wang J; Calizo A; Zhang L; Pino JC; Lyu Y; Pollard K; Zhang X; Larsson AT; Conniff E; Llosa NJ; Wood DK; Largaespada DA; Moody SE; Gosline SJ; Hirbe AC; Pratilas CA
Sci Adv; 2023 Nov; 9(47):eadg8876. PubMed ID: 38000020
[TBL] [Abstract] [Full Text] [Related]
20. Network pharmacology-based research on the effect of Scutellaria baicalensis on osteosarcoma and the underlying mechanism.
Zhang L; Tian Y; Wang J; Deng S; Fan H
Medicine (Baltimore); 2023 Nov; 102(46):e35957. PubMed ID: 37986331
[TBL] [Abstract] [Full Text] [Related]
[Next]
